Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
24
Frequently Asked Questions
What is Market Cap of Genelux Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Genelux Corp market cap is $158.65M.
What is the 52-week high for Genelux Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genelux Corp 52 week high is $5.89 as of September 27, 2025.
What is the 52-week low for Genelux Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genelux Corp 52 week low is $1.99 as of September 27, 2025.
What is Genelux Corp stock price today?
Genelux Corp stock price today is $4.20.
What was Genelux Corp stock price yesterday?
Genelux Corp stock price yesterday was $4.21.
What is the PE ratio of Genelux Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Genelux Corp’s P/E ratio is -4.90.
What is the Price-to-Book ratio of Genelux Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Genelux Corp P/B ratio is 6.5598.
What is the 50-day moving average of Genelux Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Genelux Corp 50-day moving average is $3.61.
